Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3' end processing through p21, NPAT and CDK9

Oncogene. 2010 May 13;29(19):2853-63. doi: 10.1038/onc.2010.42. Epub 2010 Mar 1.

Abstract

Proper cell cycle-dependent expression of replication-dependent histones is essential for packaging of DNA into chromatin during replication. We previously showed that cyclin-dependent kinase-9 (CDK9) controls histone H2B monoubiquitination (H2Bub1) to direct the recruitment of specific mRNA 3' end processing proteins to replication-dependent histone genes and promote proper pre-mRNA 3' end processing. We now show that p53 decreases the expression of the histone-specific transcriptional regulator Nuclear Protein, Ataxia-Telangiectasia Locus (NPAT) by inducing a G1 cell-cycle arrest, thereby affecting E2F-dependent transcription of the NPAT gene. Furthermore, NPAT is essential for histone mRNA 3' end processing and recruits CDK9 to replication-dependent histone genes. Reduced NPAT expression following p53 activation or small interfering RNA knockdown decreases CDK9 recruitment and replication-dependent histone gene transcription but increases the polyadenylation of remaining histone mRNAs. Thus, we present evidence that the induction of a G1 cell-cycle arrest (for example, following p53 accumulation) alters histone mRNA 3' end processing and uncover the first mechanism of a regulated switch in the mode of pre-mRNA 3' end processing during a normal cellular process, which may be altered during tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism*
  • Cyclin E / deficiency
  • Cyclin E / genetics
  • Cyclin-Dependent Kinase 9 / metabolism*
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism*
  • DNA Replication* / drug effects
  • E2F4 Transcription Factor / metabolism
  • G1 Phase* / drug effects
  • G1 Phase* / genetics
  • Gene Expression Regulation / drug effects
  • Gene Knockdown Techniques
  • HCT116 Cells
  • Histones / genetics*
  • Humans
  • Hydroxyurea / pharmacology
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Polyadenylation / drug effects
  • RNA 3' End Processing* / drug effects
  • RNA, Messenger / genetics
  • Retinoblastoma-Like Protein p130 / metabolism
  • Transcription Factors
  • Transcription, Genetic / drug effects
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Cell Cycle Proteins
  • Cyclin E
  • Cyclin-Dependent Kinase Inhibitor p21
  • E2F4 Transcription Factor
  • Histones
  • NPAT protein, human
  • Nuclear Proteins
  • PAF1 protein, human
  • RNA, Messenger
  • Retinoblastoma-Like Protein p130
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Cyclin-Dependent Kinase 9
  • Hydroxyurea